BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15051889)

  • 1. RBSP3 (HYA22) is a tumor suppressor gene implicated in major epithelial malignancies.
    Kashuba VI; Li J; Wang F; Senchenko VN; Protopopov A; Malyukova A; Kutsenko AS; Kadyrova E; Zabarovska VI; Muravenko OV; Zelenin AV; Kisselev LL; Kuzmin I; Minna JD; Winberg G; Ernberg I; Braga E; Lerman MI; Klein G; Zabarovsky ER
    Proc Natl Acad Sci U S A; 2004 Apr; 101(14):4906-11. PubMed ID: 15051889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer.
    Senchenko VN; Anedchenko EA; Kondratieva TT; Krasnov GS; Dmitriev AA; Zabarovska VI; Pavlova TV; Kashuba VI; Lerman MI; Zabarovsky ER
    BMC Cancer; 2010 Mar; 10():75. PubMed ID: 20193080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent alterations of hMLH1 and RBSP3/HYA22 at chromosomal 3p22.3 region in early and late-onset breast carcinoma: clinical and prognostic significance.
    Sinha S; Singh RK; Alam N; Roy A; Roychoudhury S; Panda CK
    Cancer Sci; 2008 Oct; 99(10):1984-91. PubMed ID: 19016758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies.
    Protopopov A; Kashuba V; Zabarovska VI; Muravenko OV; Lerman MI; Klein G; Zabarovsky ER
    Cancer Res; 2003 Jan; 63(2):404-12. PubMed ID: 12543795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High mutability of the tumor suppressor genes RASSF1 and RBSP3 (CTDSPL) in cancer.
    Kashuba VI; Pavlova TV; Grigorieva EV; Kutsenko A; Yenamandra SP; Li J; Wang F; Protopopov AI; Zabarovska VI; Senchenko V; Haraldson K; Eshchenko T; Kobliakova J; Vorontsova O; Kuzmin I; Braga E; Blinov VM; Kisselev LL; Zeng YX; Ernberg I; Lerman MI; Klein G; Zabarovsky ER
    PLoS One; 2009 May; 4(5):e5231. PubMed ID: 19478941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas.
    Senchenko VN; Liu J; Loginov W; Bazov I; Angeloni D; Seryogin Y; Ermilova V; Kazubskaya T; Garkavtseva R; Zabarovska VI; Kashuba VI; Kisselev LL; Minna JD; Lerman MI; Klein G; Braga EA; Zabarovsky ER
    Oncogene; 2004 Jul; 23(34):5719-28. PubMed ID: 15208675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RBSP3 is frequently altered in premalignant cervical lesions: clinical and prognostic significance.
    Mitra S; Mazumder Indra D; Bhattacharya N; Singh RK; Basu PS; Mondal RK; Roy A; Zabarovsky ER; Roychoudhury S; Panda CK
    Genes Chromosomes Cancer; 2010 Feb; 49(2):155-70. PubMed ID: 19885927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tumor suppressor gene RBSP3 in cervical carcinoma: copy number and transcriptional level].
    Anedchenko EA; Kiseleva NP; Dmitriev AA; Kiselev FL; ZabarovskiÄ­ ER; Senchenko VN
    Mol Biol (Mosk); 2007; 41(1):86-95. PubMed ID: 17380895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.
    Dammann R; Li C; Yoon JH; Chin PL; Bates S; Pfeifer GP
    Nat Genet; 2000 Jul; 25(3):315-9. PubMed ID: 10888881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel tumor suppressor candidates on chromosome 3 revealed by NotI-microarrays in cervical cancer.
    Senchenko VN; Kisseljova NP; Ivanova TA; Dmitriev AA; Krasnov GS; Kudryavtseva AV; Panasenko GV; Tsitrin EB; Lerman MI; Kisseljov FL; Kashuba VI; Zabarovsky ER
    Epigenetics; 2013 Apr; 8(4):409-20. PubMed ID: 23478628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
    Lerman MI; Minna JD
    Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of the candidate tumor suppressor gene NPRL2/G21 located in 3p21.3C.
    Li J; Wang F; Haraldson K; Protopopov A; Duh FM; Geil L; Kuzmin I; Minna JD; Stanbridge E; Braga E; Kashuba VI; Klein G; Lerman MI; Zabarovsky ER
    Cancer Res; 2004 Sep; 64(18):6438-43. PubMed ID: 15374952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Down-regulation of RBSP3/CTDSPL, NPRL2/G21, RASSF1A, ITGA9, HYAL1 and HYAL2 genes in non-small cell lung cancer].
    Anedchenko EA; Dmitriev AA; Krasnov GS; Kondrat'eva TT; Kopantsev EP; Vinogradova TV; Zinov'eva MV; Zborovskaia IB; PolotskiÄ­ BE; Sakharova OV; Kashuba VI; ZabarovskiÄ­ ER; Senchenko VN
    Mol Biol (Mosk); 2008; 42(6):965-76. PubMed ID: 19140316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion mapping using quantitative real-time PCR identifies two distinct 3p21.3 regions affected in most cervical carcinomas.
    Senchenko V; Liu J; Braga E; Mazurenko N; Loginov W; Seryogin Y; Bazov I; Protopopov A; Kisseljov FL; Kashuba V; Lerman MI; Klein G; Zabarovsky ER
    Oncogene; 2003 May; 22(19):2984-92. PubMed ID: 12771950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.
    Hogg RP; Honorio S; Martinez A; Agathanggelou A; Dallol A; Fullwood P; Weichselbaum R; Kuo MJ; Maher ER; Latif F
    Eur J Cancer; 2002 Aug; 38(12):1585-92. PubMed ID: 12142046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter methylation study of the H37/RBM5 tumor suppressor gene from the 3p21.3 human lung cancer tumor suppressor locus.
    Oh JJ; Boctor BN; Jimenez CA; Lopez R; Koegel AK; Taschereau EO; Phan DT; Jacobsen SE; Slamon DJ
    Hum Genet; 2008 Feb; 123(1):55-64. PubMed ID: 18038152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homozygous deletions but no sequence mutations in coding regions of p15 or p16 in human primary bladder tumors.
    Packenham JP; Taylor JA; Anna CH; White CM; Devereux TR
    Mol Carcinog; 1995 Nov; 14(3):147-51. PubMed ID: 7576106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma.
    Liu XQ; Chen HK; Zhang XS; Pan ZG; Li A; Feng QS; Long QX; Wang XZ; Zeng YX
    Int J Cancer; 2003 Aug; 106(1):60-5. PubMed ID: 12794757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel MECA3 region in human 3p21.3 harboring putative tumor suppressor genes and oncogenes.
    Braga E; Loginov W; Khodyrev D; Pronina I; Kazubskaya T; Bogatyrova O; Kashuba VI; Senchenko VN; Klein G; Lerman MI; Kisselev LL; Zabarovsky ER
    Exp Oncol; 2011 Mar; 33(1):33-41. PubMed ID: 21423093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
    Qiu GH; Tan LK; Loh KS; Lim CY; Srivastava G; Tsai ST; Tsao SW; Tao Q
    Oncogene; 2004 Jun; 23(27):4793-806. PubMed ID: 15122337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.